RE:RE:RE:RE:UoT rat clinical trial results r comingwhats the end game here? if we hit best case scenario and the stock does go up to $100 plus, how long will that stay there? in reality Theralase is a small player in the whole cancer research market. are the large pharm companies going to let the little guy stick around and hurt their billions of funding each year?
im not knocking the stock im just curious.